ATE155462T1 - 3-aryl-4-alkyl und 4,5-dialkyl-4h-1,2,4-triazole, verwendbar gegen gedächtnis-störungen - Google Patents
3-aryl-4-alkyl und 4,5-dialkyl-4h-1,2,4-triazole, verwendbar gegen gedächtnis-störungenInfo
- Publication number
- ATE155462T1 ATE155462T1 AT94930582T AT94930582T ATE155462T1 AT E155462 T1 ATE155462 T1 AT E155462T1 AT 94930582 T AT94930582 T AT 94930582T AT 94930582 T AT94930582 T AT 94930582T AT E155462 T1 ATE155462 T1 AT E155462T1
- Authority
- AT
- Austria
- Prior art keywords
- alkyl
- triazoles
- dialkyl
- aryl
- lower alkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14637393A | 1993-10-29 | 1993-10-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE155462T1 true ATE155462T1 (de) | 1997-08-15 |
Family
ID=22517085
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT94930582T ATE155462T1 (de) | 1993-10-29 | 1994-10-04 | 3-aryl-4-alkyl und 4,5-dialkyl-4h-1,2,4-triazole, verwendbar gegen gedächtnis-störungen |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP0725776B1 (de) |
| JP (1) | JP3779990B2 (de) |
| KR (1) | KR100321885B1 (de) |
| CN (1) | CN1046273C (de) |
| AT (1) | ATE155462T1 (de) |
| AU (1) | AU679130B2 (de) |
| CA (1) | CA2175352C (de) |
| DE (1) | DE69404322T2 (de) |
| DK (1) | DK0725776T3 (de) |
| ES (1) | ES2106567T3 (de) |
| FI (1) | FI961793A0 (de) |
| GR (1) | GR3024747T3 (de) |
| HU (1) | HUT74693A (de) |
| IL (1) | IL111404A (de) |
| NO (1) | NO961719L (de) |
| NZ (1) | NZ275620A (de) |
| WO (1) | WO1995011887A1 (de) |
| ZA (1) | ZA948352B (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2832339C (en) | 2011-04-04 | 2020-03-10 | The Procter & Gamble Company | Personal care article |
| WO2013025744A2 (en) | 2011-08-15 | 2013-02-21 | The Procter & Gamble Company | Personal care methods |
| WO2013025764A1 (en) | 2011-08-15 | 2013-02-21 | The Procter & Gamble Company | Personal care articles having multi-zone compliant personal care compositions |
| EP3013432B1 (de) | 2013-06-27 | 2018-07-25 | The Procter and Gamble Company | Zusammensetzungen und artikel zur körperpflege |
| EP3653611A1 (de) * | 2018-11-15 | 2020-05-20 | Centre National De La Recherche Scientifique | Metallo-beta-lactamase inhibitoren |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE541700C (de) * | 1928-04-08 | 1932-01-15 | C H Boehringer Sohn Akt Ges | Verfahren zur Darstellung von 1,2,4-Triazolen |
| AR243171A1 (es) * | 1985-10-29 | 1993-07-30 | Merrell Pharma Inc | Procedimiento para preparar 5-aril-2,4-dialquil-3h-1,2,4-triazol-3-tionas. |
| US5100906A (en) * | 1990-04-19 | 1992-03-31 | Merrell Dow Pharmaceuticals Inc. | 5-aryl-4-alkyl-3h-1,2,4-triazole-3-thiones useful as memory enhancers |
| US5054050A (en) * | 1990-04-30 | 1991-10-01 | American Telephone & Telegraph Co. | Drop testing in fiber to the home systems |
-
1994
- 1994-10-04 CN CN94193957A patent/CN1046273C/zh not_active Expired - Fee Related
- 1994-10-04 JP JP51264595A patent/JP3779990B2/ja not_active Expired - Fee Related
- 1994-10-04 AT AT94930582T patent/ATE155462T1/de not_active IP Right Cessation
- 1994-10-04 ES ES94930582T patent/ES2106567T3/es not_active Expired - Lifetime
- 1994-10-04 HU HU9601114A patent/HUT74693A/hu unknown
- 1994-10-04 DK DK94930582.5T patent/DK0725776T3/da active
- 1994-10-04 NZ NZ275620A patent/NZ275620A/xx unknown
- 1994-10-04 KR KR1019960702351A patent/KR100321885B1/ko not_active IP Right Cessation
- 1994-10-04 DE DE69404322T patent/DE69404322T2/de not_active Expired - Fee Related
- 1994-10-04 EP EP94930582A patent/EP0725776B1/de not_active Expired - Lifetime
- 1994-10-04 AU AU79654/94A patent/AU679130B2/en not_active Ceased
- 1994-10-04 WO PCT/US1994/011255 patent/WO1995011887A1/en active IP Right Grant
- 1994-10-04 CA CA002175352A patent/CA2175352C/en not_active Expired - Fee Related
- 1994-10-24 ZA ZA948352A patent/ZA948352B/xx unknown
- 1994-10-26 IL IL11140494A patent/IL111404A/xx not_active IP Right Cessation
-
1996
- 1996-04-26 FI FI961793A patent/FI961793A0/fi not_active IP Right Cessation
- 1996-04-29 NO NO961719A patent/NO961719L/no not_active Application Discontinuation
-
1997
- 1997-09-17 GR GR970402392T patent/GR3024747T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2175352A1 (en) | 1995-05-04 |
| CA2175352C (en) | 1999-03-02 |
| HUT74693A (en) | 1997-01-28 |
| EP0725776B1 (de) | 1997-07-16 |
| CN1046273C (zh) | 1999-11-10 |
| CN1134147A (zh) | 1996-10-23 |
| WO1995011887A1 (en) | 1995-05-04 |
| AU7965494A (en) | 1995-05-22 |
| JP3779990B2 (ja) | 2006-05-31 |
| KR100321885B1 (ko) | 2002-06-24 |
| DK0725776T3 (da) | 1997-09-01 |
| NO961719D0 (no) | 1996-04-29 |
| HU9601114D0 (en) | 1996-07-29 |
| ES2106567T3 (es) | 1997-11-01 |
| IL111404A (en) | 2000-02-17 |
| FI961793A (fi) | 1996-04-26 |
| AU679130B2 (en) | 1997-06-19 |
| EP0725776A1 (de) | 1996-08-14 |
| DE69404322D1 (de) | 1997-08-21 |
| NO961719L (no) | 1996-04-29 |
| GR3024747T3 (en) | 1997-12-31 |
| KR960705791A (ko) | 1996-11-08 |
| DE69404322T2 (de) | 1997-10-30 |
| NZ275620A (en) | 1999-01-28 |
| JPH09504290A (ja) | 1997-04-28 |
| FI961793A0 (fi) | 1996-04-26 |
| IL111404A0 (en) | 1994-12-29 |
| ZA948352B (en) | 1995-06-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69329727D1 (de) | Neue imidazol derivate, ihre herstellung und therapeutische verwendung | |
| DK0863875T3 (da) | Hidtil ukendte 4-(oxyalkoxyphenyl)-3-oxy-piperiner til behandling af hjerte- og nyrelidelser | |
| DE69820632D1 (de) | 2-phenyl-substituierte 1-(n-phenylaminoalkyl)-piperazin-derivate | |
| FI873631A (fi) | --alkyl-4-amino-3-kinolinmetanoler och 1-(4-aralkylamino-3-kinolinyl)alkanoler, foerfarande foer deras framstaellning och deras anvaendning som laekemedel. | |
| FR2712591B1 (fr) | Nouvelles arylpipérazines dérivées d'indole, leur préparation et leur utilisation thérapeutique. | |
| DE69523155T2 (de) | Benzimidazolonderivate mit zentraler dopaminerger aktivität | |
| DE69412016T2 (de) | Substituierte arylalkoxybenzyl-aminopropanamide, ihre herstellung und verwendung als antiepileptische, neuroprotektive und antidepressive mittel | |
| CO4410330A1 (es) | Nuevos derivados de bencimidazol farmacologicamente activos y sus sales de adicion acida | |
| ES2108595A1 (es) | Derivados de la 3(2h)-piridacinona y procedimiento para su preparacion. | |
| ATE155462T1 (de) | 3-aryl-4-alkyl und 4,5-dialkyl-4h-1,2,4-triazole, verwendbar gegen gedächtnis-störungen | |
| DE69402935T2 (de) | Substituierte arylalkylaminobenzyl-aminopropanamide, ihre herstellung und verwendung als antiepileptische, neuroprotektive und antidepressive mittel | |
| FI895288A0 (fi) | 1,2,3,4-tetrahydro-1,9-akridinaminer, foerfarande foer deras framstaellning och deras anvaendning som laekemedel. | |
| EP0302757A3 (de) | Antiemetisch wirksame Serotonin-Depletoren | |
| PT889044E (pt) | Derivados do 5-(heteroaril)alquil-3-oxo-pirido-(1,2-a)benzimidazole-4-carboxamida (pbi) uteis no tratamento de perturbacoes do sistema nervoso central |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |